Core Scientific, Inc./tx (CORZZ) Asset Writedowns and Impairment (2022 - 2026)

Core Scientific (CORZZ) posted Asset Writedowns and Impairment of $19.5 million for Q2 2026, down 92.68% sequentially from $266.5 million in Q1 2026.

Core Scientific, Inc./tx (CORZZ) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends

Core Scientific has reported Asset Writedowns and Impairment for 4 years, with the latest figure at $19.5 million in Q2 2026.

Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $19.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $297.4 million (up 1059.93% YoY) and the FY2025 annual result came in at $11.4 million, down 90.72% from the prior year.
Asset Writedowns and Impairment retreated to $19.5 million in Q2 2026 per CORZZ's latest filing, from $266.5 million in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $790.8 million in Q2 2022 and troughed at -$784.9 million in Q3 2022.
A 4-year average of $53.7 million and a median of $22.6 million in 2024 frame the typical range for Asset Writedowns and Impairment.
The widest YoY moves for Asset Writedowns and Impairment: up 55.54% in 2025, down 55.54% in 2025.
Over 4 years, Asset Writedowns and Impairment stood at $3.1 million in 2022, then jumped by 737.6% to $25.6 million in 2024, then plunged by 55.54% to $11.4 million in 2025, then jumped by 71.01% to $19.5 million in 2026.
According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $19.5 million, $266.5 million, and $11.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Download Data